Injective Token ETF Prompts U.S. Interest as Canary Capital Prepares to Launch

The launch of an Injective token-backed exchange-traded fund (ETF) in the United States is sparking interest within the industry. Canary Capital, a trust company based in Delaware, has officially established this trust for the proposed ETF, named ‘Canary Staked INJ ETF’. This first step signifies the asset manager’s intention to offer an investment product that provides staking exposure to the Injective (INJ) token. While creating a Delaware trust does not guarantee the launch of an ETF, it is a typical starting point for many crypto-tracking ETFs.